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Abstract
The provision of antiretroviral medications is a central component of the response to HIV/AIDS
and consumes substantial public resources from around the world, but little is known about this
intervention’s impact on the welfare of children in treated persons’ households. Using longitudinal
survey data from Kenya, we examine the relationship between the provision of treatment to adults
and the schooling and nutrition outcomes of children in their households. Weekly hours of school
attendance increase by over 20 percent within six months after treatment is initiated for the adult
patient. We find some weak evidence that young children’s short-term nutritional status also
improves. These results suggest how intrahousehold allocations of time and resources may be
altered in response to health improvements of adults.
1. Introduction
Health and education are the primary forms of human capital, critical for individual welfare
and economic development. The threat posed to children’s human capital is therefore among
the most negative and far-reaching consequence of AIDS-related morbidity and mortality in
sub-Saharan Africa. While the provision of life-saving antiretroviral (ARV) treatment has
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emerged as a central part of the medical and policy response to HIV/AIDS and consumes a
large amount of public resources from around the world, very little empirical research has
investigated the welfare effects of this important intervention on children living with treated
patients. Information on the intergenerational effects of ARV treatment can provide valuable
insights into the return on these public investments and result in well-informed public
resource allocation decisions. This paper studies how household behavior changes in
response to the provision of treatment to an infected adult in the household.
Antiretroviral treatment, which has been shown to dramatically improve patients’ health
(among many, see Hammer et al., 1997 and Wools-Kaloustian et al., 2006) as well as their
labor supply (Thirumurthy, Graff Zivin, and Goldstein, 2008; Larson et al. 2008), has the
potential to reverse the impacts of AIDS-related morbidity and mortality.2 As the labor
productivity of infected adults increases due to treatment, a combination of income and
substitution effects will allow households to become less reliant on children’s labor.3
Healthier adults will also require less care-giving from household members, further
increasing their time endowment for other activities. Jointly, the income, substitution, and
care-giving effects are likely to directly and indirectly improve the schooling outcomes of
children. The income effects are also likely to raise food consumption levels and directly
influence young children’s nutritional status. Such responses to the positive health “shock”
represented by ARV treatment would be consistent with a large literature that examines
consumption-smoothing mechanisms used by households in low-income settings with
imperfect credit and insurance markets (see, for example, Pitt and Rosenzweig, 1990;
Strauss and Thomas, 1995; Kochar, 1995; and Jacoby and Skoufias, 1997).
This paper provides evidence on how the provision of treatment affects household decisions
to invest in children’s health and schooling. In order to measure the effects of ARV
treatment, we use longitudinal socio-economic survey data collected over the course of one
year from HIV-positive adult patients who had AIDS and received free treatment. The data
include information on the schooling and nutritional outcomes of children residing in
patients’ households. We examine changes over time in these outcomes, focusing on the
weekly hours of school attended for children of school-going age and the anthropometric
status of very young children. Since the largest health gains from ARV treatment occur
within the first three months (Hammer et al., 1997; Wools-Kaloustian et al., 2006), our
primary identification strategy relies on variation in the length of time that adult patients had
been receiving treatment prior to the start of our survey. We therefore distinguish between
treatment households that had already experienced most of the health gains before the start
of our survey and those that experience them during our longitudinal survey. We also use
linked medical records for the treated adults to further examine the association between
adults’ health status and children’s outcomes.
The results in this paper provide suggestive evidence that treating adult AIDS patients with
ARVs results in substantial welfare improvements for children living with the patients. Our
results show a significant increase in children’s weekly hours of school attendance,
particularly for girls. These increases tend to occur within six to nine months after treatment
is initiated for adult patients, with no additional increases thereafter – a temporal pattern that
2A growing empirical literature finds that orphaned children in Africa experience setbacks in their schooling in the years before and
after they lose their parents (Case and Ardington, 2006; Evans and Miguel, 2007), although the severity of these impacts does vary
substantially across countries (Ainsworth and Filmer, 2006) and there is less empirical evidence on what happens in the years prior to
an adult’s death. Orphanhood has also been found to result in long-run declines in health status (Beegle, De Weerdt, and Dercon,
2006).
3A large theoretical and empirical literature examines the role of income and substitution effects in individual time allocation
decisions (beginning with Becker, 1965), family labor supply (beginning with Ashenfelter and Heckman, 1974) and household
investment decisions.
Zivin et al. Page 2













is highly consistent with the health and labor supply responses among treated adults. These
results on the short-term treatment effect are also fairly robust to the comparison group that
is used to control for confounding factors. Finally, as an important verification that the
reduced form treatment effects we estimate are driven first and foremost by the health
improvements experienced by treated adults, instrumental variables regressions show a
significant causal effect of adult health on children’s school attendance.
We find less robust evidence of short-term nutritional benefits for young children in treated
patients’ households. While the small sample size of children with anthropometric data is a
key limitation here, there is some evidence that children benefit in the early stages of
treatment. It is important to note that such improvements can have long-lasting impacts, as
early-childhood nutritional status is an important predictor of future physical and cognitive
abilities of children, as well as their labor productivity (Alderman, Behrman, Lavy, and
Menon, 2001; Alderman, Hoddinott, and Kinsey, 2006).
Due to the fact that treatment was made available to all who needed it, our study lacks data
from a sample of children living with adults who are known to have AIDS but are
exogenously denied ARV treatment (the counterfactual to our treatment group).
Consequently, our results provide suggestive but not conclusive evidence on the impact of
AIDS treatment on the schooling and health of children living with treated adults. Since the
health of adults with AIDS would rapidly decline in the absence of treatment and almost
certainly result in death within one year, we suspect that our approach will under-estimate
treatment impacts. But we cannot rule out the possibility that children’s schooling would
improve once their parent is gone, thus making our results an over-estimate. Nonetheless,
based on several empirical strategies, the findings in our paper provide suggestive evidence
of sizable benefits to children living in the households of adults who receive ARV treatment.
The next section provides background on the treatment intervention that we study, as well as
the household survey data. This is followed by a discussion in Section 3 of our strategy for
estimating the relationship between ARV treatment and children’s outcomes. Regression
results showing the effect of treatment on children’s schooling and nutrition are presented in
Section 4. Section 5 contains further interpretation of our results and discusses their policy
implications.
2. Background and Data
The paper uses data from a household survey we conducted in Kosirai Division, a rural
region near the town of Eldoret in western Kenya. Our study and sample design are
described in an online Appendix and additional details are also in Thirumurthy, Graff Zivin,
and Goldstein (2008). Here we provide a brief description of ARV treatment and the data
used in our analysis of nutrition and education outcomes.
Almost all HIV-infected individuals experience a weakening of the immune system and
progress to developing AIDS. This later stage is associated with substantial weight loss
(wasting) and opportunistic infections such as pneumonia and tuberculosis. Once individuals
develop AIDS, death is highly imminent without treatment. Highly active antiretroviral
therapy4 has been proven to reduce the likelihood of opportunistic infections and prolong
the life of HIV-infected individuals. According to WHO guidelines, this treatment should be
initiated around the time that individuals progress to AIDS (WHO, 2002). After several
months of treatment, patients are generally asymptomatic and have improved functional
4In this paper, we use the terms “ARV therapy” and “ARV treatment” interchangeably to refer to highly active antiretroviral therapy
(HAART).
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capacity.5 While the effect of ARV therapy on the health of treated patients has been widely
documented, much less is known about the broader impact it can have on the social and
economic outcomes of patients and their families. Our survey in Kenya was designed to
assess these impacts.
Households in the survey area are scattered across more than 100 villages where crop
farming and animal husbandry are the primary economic activities and maize is the main
crop. The largest health care provider in the survey area is a government-run health center
that offers primary care services. The health center also contains a clinic that provides free
medical care (including ARV therapy) to HIV-infected individuals. This rural HIV clinic—
one of the first in sub-Saharan Africa—was opened in November 2001 by the Academic
Model Providing Access to Health Care (AMPATH). Since late-2003, AMPATH has had
adequate funding to provide ARV therapy to all patients who are eligible according to the
WHO guidelines.
We conducted two rounds of interviews between March 2004 and March 2005, with an
interval of roughly six months between rounds. Our survey included 206 households with at
least one known HIV-positive adult who began receiving ARV therapy at the AMPATH
clinic prior to the round 2 interview (ARV households). Variation within this sample in the
amount of time that adult patients were on treatment at the start of our survey is an important
part of our analysis, as we discuss in Section 3. Our survey also included 503 households
that were chosen randomly from the survey area. We use these data to perform additional
tests of our assumptions regarding the trajectory of health benefits following treatment
initiation.
When analyzing schooling outcomes, we focus on children who were between the ages of 8
and 18 in round 1 and resided in households that were interviewed in both rounds during
non-holiday periods. The schooling outcome we examine is the number of hours of school
attended by the child in the seven days prior to the interview (excluding travel time to and
from the school). Our analysis uses data for 480 children (from 246 households) – 128
children in ARV households and 352 children in random sample households. Attrition of
children in round 2 is less than 5 percent in each of the study groups.
The primary nutritional outcome we examine is the weight-for-height Z-score – a measure
of thinness or wasting that is particularly sensitive to short-term growth disturbances caused
by factors such as inadequate food and illnesses (Waterlow et al., 1977; WHO Working
Group, 1986; WHO, 1995). As such, it represents a current estimate of nutritional status and
can exhibit considerable variation over short periods of time. The heights and weights of
children less than 5 years of age were measured during household visits in each round. The
sample for our analysis of nutritional outcomes uses data for 41 uninfected children (from
30 ARV households) and 349 uninfected children (from 238 random sample households).
3. Empirical Strategy
This section provides an overview of our empirical strategy for estimating the relationship
between ARV therapy and outcomes of children in treated households. Central to our
identification strategy is the considerable variation in treatment initiation dates within the
ARV households – 22 percent began treatment shortly after the round 1 interview, an
additional 27 percent were on treatment for less than 3 months at the time of the round 1
interview, and the remainder had been on treatment for more than 3 months at the time of
5See, for example, Koenig, Leandre, and Farmer, 2004 or Wools-Kaloustian et al., 2006, as well as the results in Thirumurthy, Graff
Zivin, and Goldstein, 2008.
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the round 1 interview. Since the health and labor supply response for treated patients is
nonlinear and largest in the first three months of treatment, and small to nonexistent
thereafter (Wools-Kaloustian et al., 2006; Thirumurthy, Graff Zivin, and Goldstein, 2008),
our estimation strategy exploits this underlying heterogeneity.
Specifically, we divide the sample of children in ARV households into two sub-groups that
—as we show further below—experience very different changes in adult health between the
two survey rounds: (a) children living in households where the adult patient began receiving
treatment more than 100 days before round 1 (later-stage treatment group that does not
experience health changes between rounds), and (b) children living in households where the
adult patient began receiving treatment 100 or fewer days before round 1 or very shortly
after round 1 began (early-stage treatment group that experiences large health changes
between rounds).6 Since treatment is initiated at the onset of AIDS, it should be noted that in
the early-stage ARV households, treated adults are generally very sick during the round 1
interview. Our first empirical approach then compares the trends in children’s outcome
variables for the two treatment sub-groups:
(1)
Yiht is the outcome of interest (school attendance and nutritional status) for child i in
household h at time t (round 1 or 2), αih is a fixed effect for child i in household h, and
ARVHH<100,h is equal to 1 if household h has an adult who was receiving ARV therapy for
100 of fewer days at the time of the round 1 interview (early-stage ARV households), and
ROUND2t indicates whether the observation is from round 2. Also included are eleven
month-of-interview indicator variables that control for monthly fluctuations in outcomes that
are common to the “treatment” and comparison groups. In equation 1 the later-stage ARV
households, which are not experiencing significant changes in adult health between rounds,
serve as the comparison group for early-stage treatment households. This allows us to
control for the effects of time-varying factors such as seasonal fluctuations in weather, labor
demand, malaria, and food availability – all of which are likely to influence children’s
outcomes in our setting. Specifically, the coefficient β1 represents the treatment effect
during the first 6–9 months after ARV therapy is initiated. If the schooling and nutrition
outcomes for children of treated adults are being driven by changes in the health and labor
supply of treated adults, we would expect β1 to be positive.
This estimation strategy relies on two key assumptions. First, it requires that adult patients in
early-stage treatment households experience much larger health improvements between
survey rounds than patients in later-stage treatment households. As we show in results
below, this assumption is well supported by the AMPATH medical records, which reveal
much larger weight and CD4 gains for patients in the early stages of treatment. Second, it is
assumed that in the absence of large health improvements due to ARV treatment, the trends
in schooling and nutrition for children in early-stage households would be similar to those
for later-stage households. This second assumption is more difficult to substantiate since the
time at which adults enroll in the treatment program is not randomly determined, but in
6In the sample of children we use for the schooling analysis, the median number of days that adult patients have been on ARV therapy
as of round 1 is 99.5. The average is considerably higher (167), and the 25th and 75th percentiles are 10.5 and 285. While health
impacts are clearly concentrated in the early months of treatment, the choice of 100 days as the cutoff is still to some extent arbitrary.
Experimentation with cutoffs ranging from 90–110 days does not change our results. In addition to evidence that the largest health
gains from ARV therapy occur within the first three months of treatment, the adult patients on treatment for less than 100 days as of
round 1 have also been found to experience the largest increase in labor supply between rounds 1 and 2 (Thirumurthy, Graff Zivin,
and Goldstein, 2008).
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Section 4 we present suggestive evidence in its favor by showing that treated adults in the
early- and later-stage treatment households had similar health status at the time of treatment
initiation. Given this, the difference in timing of treatment initiation within the ARV sample
is likely to have been determined by the date when patients became infected with HIV,
which was roughly 8–10 years preceding these observations. The long period of disease
progression suggests that the timing of treatment initiation is plausibly exogenous.
Furthermore, we find that patients’ demographic characteristics and wealth measures – both
of which could affect schooling and nutrition trends – are not significantly different at the
time of the round 1 interview.
As an additional check on the validity of the identifying assumptions for equation 1, we
estimate an alternative specification in which we directly compare each of the two types of
ARV households to children in the random sample of households:
(2)
ARVHH>100,h is equal to 1 if household h has an adult who was receiving ARV therapy for
more than 100 days at the time of the round 1 interview (later-stage ARV households).
When estimating equation 2, we will be interested both in the magnitudes of β1 and β2, as
well the difference between the two coefficients. Since adults in later-stage ARV households
do not experience large changes in health status between rounds, β2 should not be
significantly different from zero as long as it is the case that the seasonal and idiosyncratic
schooling and nutrition trends for children in random sample and late-stage ARV
households are similar. This is an important advantage of equation 2 over equation 1, as it
includes a “falsification test” that further probes the relationship between adult health and
children’s welfare. In contrast to our expectation about β2, the large health gains for early-
stage treatment households lead us to expect that β1 is positive and significantly different
from zero. Again, our assumption here is that children in the random sample represent a
proper control for seasonal and idiosyncratic determinants of outcomes.
The magnitude of β1 in both equations 1 and 2, however, should be interpreted with caution.
The identifying assumptions described above allow us to measure the impacts of treatment
relative to those households that experience small or no health changes between survey
rounds. But since adults with AIDS would experience dramatic health declines (and even
mortality) in the absence of ARV therapy, neither of the comparison groups in equations 1
or 2 are an ideal representation of the counterfactual scenario. As is suggested by the
literature on orphans and vulnerable children in Africa, it is quite likely that the deterioration
of adult health would lead to declines in children’s health and schooling, in which case β1
would be an underestimate of the impact of treatment. On the other hand, we cannot rule out
the possibility that β1 is an overestimate, since children who lose a parent to AIDS may be
taken in by relatives or friends and experience improvements in their health and schooling.
Finally, to verify that adult health improvements due to ARV treatment are indeed driving
changes in children’s outcomes, we use an instrumental variables (IV) strategy to explore
the relationship between children’s schooling and adult health.7 We do this by merging our
survey data with information from the AMPATH medical records on the weight of the adult
7Given the limited sample size for our analysis of nutritional status, we only implement the IV strategy for children’s school
attendance.
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patients being treated (a standard indicator of health responses to ARV therapy).
Specifically, we first estimate the following equation
(3)
in which WEIGHTht is the predicted body weight of the treated adult patient in household h
at time t (round 1 and 2), as predicted by the following first-stage equation:
(4)
In the first-stage equation (4), the coefficient β1 should illustrate the effect that has been
shown in the medical literature and that we have reported elsewhere for the sample of
patients in this study (Thirumurthy, Graff Zivin, and Goldstein, 2008): ARV therapy results
in large increases in patients’ weight during the early stages of treatment, after which weight
gains are minimal.
The results from estimating the equations above with school attendance as the dependent
variable will reveal how ARV treatment affects schooling outcomes of children in treated
patients’ households, relative to their round 1 levels. Since the survey recorded information
on the hours of market labor performed by children in the week prior to interview, we can
also compare the treatment effect on schooling to that on labor supply, thereby examining
whether changes in schooling are offset by changes in labor supply. Thus, as an extension of
our analysis, we estimate the equations with children’s labor supply as the dependent
variable.
4. Results
Table 1 compares the main characteristics in round 1 of households belonging to random
sample households and the two different groups of ARV households (denoted ARVHH<100
and ARVHH>100 above). We only report statistics for households that have children between
the ages of 8–18 years and were interviewed during non-holiday periods in both rounds (a
total of 480 children). Compared to random sample households, both groups of ARV
households have significantly different demographic composition. The ARV households are
more likely to be headed by single (and often widowed) women. When comparing
demographic characteristics of the two groups of ARV households, however, we do not
observe any significant differences (column 9 reveals that the p-values from t-tests of
equality of means are above 0.10). Turning to the various wealth measures (land holdings,
land value, and the value of livestock), we do not find significant differences between
random sample households and either group of ARV households, nor between the two
groups of ARV households. Since so many of the households in our survey are engaged in
own-farm agricultural activities, these similarities in landholdings suggest that weather
patterns in the survey area should not have heterogeneous effects on the labor demand and
socio-economic status of these groups of households. Such similarities are important for our
empirical approach since the “control groups” we define are meant to correct for seasonal
and other time-varying aggregate predictors of children’s schooling and nutrition. Moreover,
retrospective data from patients’ medical records show that the two groups of ARV
recipients had similar health status (as measured by body weight) at the time of treatment
initiation, providing additional support for one of the identifying assumptions underlying
equations 1 and 2.
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Identification in equations 1 and 2 also depends upon variation in the amount of health
improvement in ARV households between survey rounds. Summary statistics in Table 1
reveal much larger gains in body weight for early-stage ARV recipients and modest gains
for those in the later stages of treatment. This is further evident in the results from estimating
equation 4. Table 2 shows that, consistent with findings in the medical literature, there are
significantly larger weight gains during the early stages of ARV therapy. On average, adults
on treatment for 100 or fewer days in round 1 gain an additional 6–7 kilograms between
rounds than do adults on treatment for more than 100 days in round 1. This large point
estimate of 6.4 kilograms – a greater than 10 percent weight increase – is highly consistent
with the dramatic health improvements during the first three months of ARV therapy that
have been documented elsewhere (e.g. Wools-Kaloustian et al., 2006). This health
improvement also translates into increased labor supply for adults in the early stages of
treatment, as our earlier work has shown. The remainder of this section tests whether
schooling and health outcomes of children also improve as a result of these changes in adult
health.
4.1 Effect of treatment on children’s schooling
The summary statistics in Table 3 show that in round 1, children in early-stage ARV
households have the lowest level of school attendance. Their weekly hours of schooling
averaged about 28 hours, significantly fewer than the roughly 34 hours of weekly schooling
for children in the random sample and later-stage ARV households.8 While merely cross-
sectional comparisons, these round 1 statistics suggest that children are worst off in the very
early stages of treatment, but that over time they catch up to others in their community.
When we consider the changes between rounds 1 and 2 for children in each group of
households, it appears that relative to children in random sample and later-stage ARV
households, children in early-stage ARV households are better off. Although there is a
secular decline in weekly hours of schooling between round 1 and round 2, the advantage of
our empirical strategy is that it controls for such secular trends – which could be due to the
fact that the agricultural harvest occurs during round 2. Table 3 also reveals that the market
labor supply of children in both types of ARV households declines considerably between
rounds, whereas it is largely unchanged for children in random sample households.
Our main results come from implementing the three empirical strategies discussed in
Section 3, which take advantage of the longitudinal data by using child fixed effects and also
make use of linked information on the health status of adult patients in the ARV households.
The first panel of Table 4 reports results obtained when boys and girls are both included in
the regressions, whereas Panels B and C report the results for boys and girls separately. The
first two columns of Panel A show a similar increase over time in school attendance for
children in early-stage ARV households, relative to children in later-stage ARV households
(column 1) as well as random sample households (column 2). Our results indicate that
children in early-stage ARV households experience a gain of 6 hours in weekly school
attendance, roughly an entire school day and an amount equivalent to more than 20 percent
of their average round 1 attendance levels. The fact that children in early-stage ARV
households have a similar improvement relative to children in both later-stage ARV
households and random sample households suggests that the latter two groups have similar
schooling trends during the survey period, and that the random sample households are not
necessarily an imperfect control group for seasonal trends. This is further verified by the
result in column 2 of Panel A, which shows that compared to the random sample, children in
later-stage ARV households do not experience any significant change in school attendance.
8A full day of school will typically last 6–8 hours, with the longer school days being more common at higher school levels. Perfect
school attendance is therefore in the range of 30–40 hours, depending on the child’s school level.
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The result is consistent with the fact that in later-stage ARV households much of the
improvement in the treated adult’s health has already occurred by round 1, and it provides
added evidence that the estimated improvements in schooling for children in early-stage
ARV households are primarily due to health improvements of the treated adults in their
households. Furthermore, it should be noted that the pattern in column 2 of large increases in
the early stages of treatment followed by no significant changes beyond 6–9 months of
treatment is very similar what we observed in the treated adults’ health status (Table 2) and
labor supply (see Thirumurthy, Goldstein, and Graff Zivin 2008).9
The third column in Table 4 reports results from implementing the instrumental variables
strategy described by equations 3 and 4. This is meant to verify whether increases in
children’s school attendance occur in the same households that also experience
improvements in adult health. The first stage results from the IV strategy (Table 2)
underscored the distinction between the two types of ARV households in our sample. The
second stage results, in column 3 of Table 4, indicate a positive and significant relationship
between adult weight and children’s school attendance. For the sample of all children in
ARV households, a 1 kilogram increase in the weight of the adult patient leads to an
increase of almost 0.9 hours in weekly school attendance. A direct association can therefore
be made between the treatment-induced improvements in adult health and the school
attendance patterns of children.
Table 4 also shows the results from estimating separate treatment effects for boys and girls.
The most notable finding here is that schooling increases for girls are more concentrated
during the early stages of treatment, whereas for boys there is less direct evidence that
school attendance closely tracks adult health improvements. In column 1 of Panel B, we
show that relative to boys in later-stage ARV households, there is a positive but statistically
insignificant treatment effect for boys in early-stage ARV households. Column 2 suggests
that the absence of a treatment effect for boys in newly treated households is largely due to
the fact that those in later-stage ARV households also have rising school attendance (relative
to boys in random sample households). While our results in panel B cast doubt on the
hypothesis that ARV therapy alone results in higher school attendance for boys, an
alternative possibility that we cannot explicitly test for is that the treatment effect on school
attendance takes longer to fully manifest for boys. Finally, while the IV results in column 3
of Panel B indicate a positive effect of adult health on boys’ school attendance, the
estimated coefficient is not statistically significant.
The treatment effect for girls, on the other hand, is large and significant during the early
stages of ARV therapy for treated adults. Compared to children in later-stage ARV
households, girls in early-stage ARV households have a significant increase of 8.9 hours in
weekly school attendance. The results are similar when we make comparisons to girls in the
random sample. The estimated treatments effect for girls in early-stage ARV household is
large and significant (6.5 hours), but not significantly different from zero for girls in later-
stage ARV households. Moreover, we find that under the IV strategy, the treated adults’
weight has a large and significant effect on the school attendance of girls. These results
indicate a strong relationship between the provision of treatment to adults and the school
attendance of girls in particular.10
9We also performed tests for the equality of the two coefficients β1 and β2 in equation 2. When we pool all children (panel A), we
cannot reject the hypothesis that the coefficients are equal. However, for girls (panel C), the coefficient for ARVHH<100*Rd.2 is
significantly different, at the 10% level, from the coefficient for ARVHH>100*Rd.2.10In our empirical work we also tested whether treatment effects differ for boys and girls of different age groups, such as primary
school age children (8–14 in round 1) and older children (14–18 in round 1). Our results, while not reported here, suggest that young
boys and girls experience the bulk of the attendance increases stemming from treatment provision.
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To further explore how the schooling effects relate to households’ time allocation decisions
more generally, we also examined the effect of treatment on children’s weekly hours of
market labor supply. The dependent variable in this case is the reported number of hours in
the past week that a child spent working on income-generating activities. In Panel A of
Table 5, we find only limited evidence that treatment provision to adults with AIDS leads to
reductions in children’s labor supply. This average effect seems to mask heterogeneity by
gender. In Panel B, we show that compared to boys in later-stage ARV households, those in
early-stage households do not experience significantly different trends in labor supply. But
compared to boys in random sample households, boys in both types of ARV households
experience a significant decline in labor supply. This is similar to the pattern for boys’
school attendance, with significant increases for both groups of ARV households. Consistent
with the first two sets of results for boys, the instrumental variables strategy (in column 3 of
Table 5) reveals a negative but statistically insignificant relationship between adult health
and labor supply. Panel C shows that there are no significant effects of treatment on the
market labor supply of girls either. In summary, these results do not provide strong evidence
that the provision of ARV therapy to adults goes on to influence – through income and
substitution effects – children’s market labor supply.11
Thus, the schooling gains due to treatment must be primarily the result of reductions in non-
market labor (including caring for sick adults) and/or leisure. Indeed, in another paper that
examines the association between treatment provision and time allocation to various
household tasks (using a third round of follow-up data since the second round did not
include comprehensive time allocation information), we find a significant reduction in the
time that girls spend fetching water, as well as an effect on housework for boys (D’Adda et
al., forthcoming).
4.2 Effect of treatment on children’s nutritional status
As ARV therapy improves the health and productivity of HIV-infected adults, income
effects may allow treated households to consume more food. This could in turn improve the
nutritional status of household members, particularly children. We explore this possibility by
examining the nutritional status of very young children (aged 0–5 years) residing in ARV
households.
Table 6 presents summary statistics for the anthropometric status of children measured in
both rounds of the survey. The most striking pattern here is that children in the early-stages
have a large increase in their weight-for-age Z-score between rounds 1 and 2, relative to the
changes for children in random sample and ARV households. To establish whether these
changes in the nutritional status of children are related to the provision of ARV treatment to
adults and not to other factors such as seasonality and aggregate shocks, we use the
longitudinal data to estimate equations 1 and 2.12 As column 1 of Table 7 indicates, relative
to children in later-stage ARV households, those in early-stage ARV households do not
experience a significant change in their Z-score. The small number of observations is a
major limitation in making such a comparison, however. Relative to children in random
sample households, we do find that a significant increase in Z-scores for children in early-
stage ARV households. Weight-for-height of children in the latter households increases by
0.60 standard deviations in the six months between survey rounds, representing a substantial
11The results presented here differ from those in Thirumurthy, Graff Zivin, and Goldstein (2008), as our analysis here is restricted to
children in households that were interviewed during non-holiday periods.
12We also include interviewer fixed effects because the measurement of heights in small children is challenging and can vary with
individual skills and experience. In addition, following the recommendations in WHO (1995), the 9 observations with weight-for-
height Z-score or height-for-age Z-score larger than 6 or smaller than −6 are excluded from the analysis. We also include age controls
because the interval between measurements is not exactly six months for all children. Finally, due to the small size of the ARV
sample, we do not estimate regressions separately for boys and girls.
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improvement in nutritional status.13 Children in later-stage ARV households, on the other
hand, have no significant change in Z-scores relative to children in random sample
households. The estimated treatment effect for them is close to being significantly lower
than the effect for children in later-stage ARV households (p-value of 0.14). The different
trends for children in the two types of ARV households provide suggestive evidence that the
increased height-for-age Z-score of children in the early-stage ARV households are indeed
due to the improving economic conditions in these households. However, the lack of a
treatment effect in column 1 means that the effects in column 2 may be driven by
differential trends among children in the random sample, and this leads us qualify our
conclusions about the effect of treatment on children’s nutritional status.
5. Discussion and Policy Implications
The results in this paper suggest that the provision of ARV therapy to adults with AIDS
generates benefits often overlooked in the existing literature. After controlling for
confounding factors, we find that children in households of treated adults attend more
school. We also find suggestive evidence that young children in such households are better
nourished. Particularly noteworthy is the consistency in the timing of these impacts with the
health and labor impacts experienced by adults -- most changes occur within six to nine
months after treatment is initiated.
To identify the various economic factors that drive our results it is worth noting that the
most immediate impacts of ARV therapy are on treated patients, who experience large and
immediate restorations in their health, functional capacity, and labor supply. These dramatic
changes in the health and labor supply of working-age adults could affect their household
members in several ways. First, the income effect from increased adult labor supply will
result in higher food consumption, greater ability to pay school-related expenses, and
reduced need for children and other household members to work. Second, since the relative
productivity of treated patients’ children will be lower, the substitution effect will reduce the
labor supply of children. Third, children and other household members will have to provide
less home-based care for treated adults. All of these factors should directly improve the
educational status of children, and the income effect should directly improve their nutritional
status. Moreover, the treatment of adults may also affect children’s schooling indirectly
through its effects of children’s health (Miguel and Kremer, 2005).14 While we cannot
establish the size of each of these effects independently, our instrumental variables results
link adult health to schooling outcomes and show that – at the very least – the improvements
in adult health due to ARV therapy are a central part of the reason why children’s school
attendance increases.
Taken as a whole, our results have important implications for how one should generally
value public expenditures on HIV/AIDS or other large-scale health interventions. Most
research in this area denominates the returns to these programs in some metric of health,
measures that are focused on morbidity and mortality impacts for patients. Even the use of
quality- (or disability-) adjusted-life-years saved, which under certain conditions can capture
patient income effects, still misses the important non-patient impacts described in this paper.
Given the high returns to children’s human capital, our results suggest that a more careful
cost-benefit analysis of treatment is necessary.
13Since height-for-age is an anthropometric index that changes slowly, children are unlikely to experience large changes over the
course of six months. When examined as an outcome variable, it is reassuring that we find no significant changes in the height-for-age
Z-scores of children living with ARV recipients.
14There is also the possibility that treated parents expect that they and their children will live longer due to treatment availability, and
therefore invest more in their children’s education.
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Future work should extend our analysis to include a range of other household-level
outcomes that may be influenced by treatment, including investment in natural capital and
physical assets. Two limitations of our study – the relatively small sample size of treated
patients, and the single study site – could be overcome by larger studies conducted across
multiple treatment sites that would provide insights on the generalizability of our findings.
The HIV/AIDS epidemic and our response to it appear to influence household investment
decisions that create an inextricable link between the welfare of current and future
generations in countries heavily impacted by the disease. As further public investments are
considered or re-considered, deepening our understanding of these linkages should be a
priority.
References
Ainsworth, Martha; Filmer, Deon. Inequalities in Children’s Schooling: AIDS, Orphanhood, Poverty,
and Gender. World Development. 2006; 34:1099–1128.
Alderman, Harold; Behrman, Jere R.; Lavy, Victor; Menon, Rekha. Child Health and School
Enrollment: A Longitudinal Analysis. The Journal of Human Resources. 2001; 36:186–205.
Alderman, Harold; Hoddinott, John; Kinsey, Bill. Long Term Consequences of Early Childhood
Malnutrition. Oxford Economic Papers. 2006; 58:450–474.
Ashenfelter, Orley; Heckman, James. The Estimation of Income and Substitution Effects in a Model of
Family Labor Supply. Econometrica. 1974; 42:73–86.
Becker, Gary. A Theory of the Allocation of Time. Economic Journal. 1965; 75:493–517.
Beegle, Kathleen; De Weerdt, Joachim; Dercon, Stefan. Orphanhood and the Long-Run Impact on
Children. American Journal of Agricultural Economics. 2006; 88:1266–1272.
Case, Anne; Ardington, Cally. The Impact of Parental Death on School Outcomes: Longitudinal
Evidence from South Africa. Demography. 2006; 43:401–420. [PubMed: 17051820]
D’Adda, Giovanna; Goldstein, Markus; Zivin, Joshua Graff; Nangami, Mabel; Thirumurthy, Harsha.
ARV Treatment and Time Allocation to Household Tasks: Evidence from Kenya. African
Development Review. Forthcoming.
Evans, David; Miguel, Edward A. Orphans and Schooling: A Longitudinal Analysis. Demography.
2007; 44:35–57. [PubMed: 17461335]
Jacoby, Hanan G.; Skoufias, Emmanuel. Risk, Financial Markets, and Human Capital in a Developing
Country. Review of Economic Studies. 1997; 64:311–335.
Kochar, Anjini. Explaining Household Vulnerability to Idiosyncratic Income Shocks. The American
Economic Review Papers and Proceedings. 1995; 85:159–164.
Koenig, Serena P.; Leandre, Fernet; Farmer, Paul E. Scaling-up HIV Treatment Programmes in
Resource-Limited Settings: The Rural Haiti Experience. AIDS. 2004; 18:S21–S25. [PubMed:
15322480]
Larson, Bruce A., et al. Early Effects of Antiretroviral Therapy on Work Performance: Preliminary
Results from a Cohort Study of Kenyan Agricultural Workers. AIDS. 2008; 22:421–425.
[PubMed: 18195569]
Miguel, Edward; Kremer, Michael. Worms : Identifying Impacts on Education and Health in the
Presence of Treatment Externalities. Econometrica. 2004; 72:159–217.
Pitt, Mark; Rosenzweig, Mark. Estimating the Intrahousehold Incidence of Illness: Child Health and
Gender-Inequality in the Allocation of Time. International Economic Review. 1990; 31:969–989.
Strauss, John; Thomas, Duncan. Human Resource: Empirical Modeling of Household and Family
Decisions. In: Behrman, Jere; Srinivasan, TN., editors. Handbook of Development Economics.
Vol. 3. 1995.
Thirumurthy, Harsha; Zivin, Joshua Graff; Goldstein, Markus. The Economic Impact of AIDS
Treatment: Labor Supply in Western Kenya. Journal of Human Resources. 2008; 18:511–552.
Waterlow JC, et al. The Presentation and Use of Height and Weight Data for Comparing the
Nutritional Status of Groups of Children Under the Age of 10 Years. Bulletin of the World Health
Organization. 1977; 55:489–498. [PubMed: 304391]
Zivin et al. Page 12













Wools-Kaloustian, Kara, et al. Viability and Effectiveness of Large-scale HIV Treatment Initiatives in
Sub-Saharan Africa: Experience from Western Kenya. AIDS. 2006; 20:41–48. [PubMed:
16327318]
World Health Organization. Physical Status: The Use and Interpretation of Anthropometry. Report of a
WHO Expert Committee. World Health Organization Technical Report Series. 1995; 854:1–452.
[PubMed: 8594834]
World Health Organization. Scaling Up Antiretroviral Therapy in Resource-Limited Settings:
Guidelines for a Public Health Approach. Geneva: World Health Organization; 2002.
World Health Organization Working Group. Use and Interpretation of Anthropometric Indicators of
Nutritional Status. Bulletin of the World Health Organization. 1986; 64:929–941. [PubMed:
3493862]
Zivin et al. Page 13












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Zivin et al. Page 16
Table 2
Relationship Between ARV Treatment and Adult Health
(1) (2) (3)
Dependent variable: Weight (kilograms) of adult patient
All kids Boys Girls
ARV hh <100 days * Round 2 6.385 (1.012)*** 6.402 (1.611)*** 7.728 (1.289)***
Constant 64.859 (7.190)*** 56.429 (1.550)*** 63.100 (9.043)***
Observations 251 120 131
R-squared 0.95 0.94 0.97
Notes: Standard errors in parentheses are clustered at the household level in each round (** significant at 5%; *** significant at 1%). The table
reports results from estimating equation 4 in the paper. All regressions include individual fixed effects, as well as month-of-interview indicators.
Observations for which school attendance was reported to be below normal because of school holidays during the past week are excluded from the
sample.
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Table 4
ARV Treatment and Children’s School Attendance
(1) (2) (3)









households only (equation 3)
Panel A: All children
ARV hh (<100 days) * Round 2 6.033 (2.934)** 6.393 (2.792)**
ARV hh (>100 days) * Round 2 1.893 (2.548)
Weight of adult patient (instrumented) 0.889 (0.408)**
Observations 256 964 251
R-squared 0.88 0.83
Panel B: Boys
ARV hh (<100 days) * Round 2 6.089 (3.772) 8.673 (3.854)**
ARV hh (>100 days) * Round 2 4.902 (2.770)*
Weight of adult patient (instrumented) 0.851 (0.596)
Observations 124 522 120
R-squared 0.88 0.83
Panel C: Girls
ARV hh (<100 days) * Round 2 8.908 (4.229)** 6.513 (3.241)**
ARV hh (>100 days) * Round 2 −1.035 (3.941)
Weight of adult patient (instrumented) 1.147 (0.515)**
Observations 132 442 131
R-squared 0.89 0.85
Notes: Standard errors in parentheses are clustered at the household level in each round (* significant at 10%; ** significant at 5%; *** significant
at 1%). The dependent variable is the total number of hours the child spent in school during the week prior to interview. Column 1 reports results
from estimating equation 1 in the paper; column 2 reports results from estimating equation 2; and column 3 reports results from estimating equation
3. All regressions include child fixed effects and month-of-interview indicators. Panel A reports results for samples containing boys and girls; panel
B reports results for samples of boys only; and Panel C reports results from samples of girls only. Observations for which school attendance was
reported to be below normal due to school holidays during the past week are excluded from the sample.
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Table 5
ARV Treatment and Children’s Market Labor Supply
(1) (2) (3)











Panel A: All children
ARV hh (<100 days) * Round 2 −1.915 (3.542) −4.576 (2.040)**
ARV hh (>100 days) * Round 2 −3.305 (1.995)*
Weight of adult patient (instrumented) −0.289 (0.497)
Observations 256 916 233
R-squared 0.88 0.78
Panel B: Boys
ARV hh (<100 days) * Round 2 −1.958 (4.893) −7.606 (3.181)**
ARV hh (>100 days) * Round 2 −7.593 (2.896)***
Weight of adult patient (instrumented) −0.441 (0.742)
Observations 114 502 110
R-squared 0.90 0.82
Panel C: Girls
ARV hh (<100 days) * Round 2 −0.921 (4.908) −0.793 (2.734)
ARV hh (>100 days) * Round 2 1.200 (2.835)
Weight of adult patient (instrumented) −0.129 (0.645)
Observations 124 414 123
R-squared 0.71 0.68
Notes: Standard errors in parentheses are clustered at the household level in each round (* significant at 10%; ** significant at 5%; *** significant
at 1%). The dependent variable is the total number of hours devoted to income-generating activities in the past week. Column 1 reports results from
estimating equation 1 in the paper; column 2 reports results from estimating equation 2; and column 3 reports results from estimating equation 3.
All regressions include child fixed effects and month-of-interview indicators. Panel A reports results for samples containing boys and girls; panel B
reports results for samples of boys only; and Panel C reports results from samples of girls only. Observations for which school attendance was
reported to be below normal due to school holidays during the past week are excluded from the sample. The number of observations is slightly
smaller than the number of observations in Table 4 because labor supply information is missing for 44 children.





























































































































































































































































































































































































































































































































































































































































































































































































































































Zivin et al. Page 21
Table 7
ARV Treatment and Children’s Anthropometric Status
(1) (2)
Dependent variable: Weight-for-height Z-score
Sample and specification:
Comparison within ARV households
(equation 1)
Comparison between ARV and random sample
households (equation 2)
All children
ARV hh (<100 days) * Round 2 0.374 (0.784) 0.598 (0.279)**
ARV hh (>100 days) * Round 2 0.078 (0.258)
Observations 81 773
R-squared 0.92 0.87
Notes: Standard errors in parentheses are clustered at the household level in each round (** significant at 5%; *** significant at 1%). The
dependent variable is the Weight-for-Height Z-score, which is calculated from the measured weights and heights of children and based on
comparison to a well-nourished reference population of children in the U.S. Column 1 reports results from estimating equation 1 in the paper and
column 2 reports results from estimating equation 2. All regressions include child fixed effects, fixed effects for the interviewer who measured the
child, month-of-interview indicators, and age controls. Observations with weight-for-height Z-score or height-for-age Z-score larger than 6 or
smaller than −6 are excluded from the analysis.
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